why choose us

First received: November 20, 2023

Clinical Trial: A Trial to Learn if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Participants With Follicular Lymphoma and Marginal Zone Lymphoma

Study Status: Completed

Recruit Status: RECRUITING

Condition: Relapsed/Refractory Follicular Lymphoma

Study Type: INTERVENTIONAL


Official Title: A Phase 3, Open Label, Randomized Study to Compare the Efficacy and Safety of Odronextamab (REGN1979), an Anti-CD20 x Anti-CD3 Bispecific Antibody, in Combination With Lenalidomide Versus Rituximab in

Brief Summary: This study is researching an experimental drug called odronextamab, referred to as study drug.The study is focused on patients who have one of two types of cancer: follicular lymphoma (FL) or marginal zone lymphoma (MZL) that has come back after treatment (called "relapsed"), or did not respond to treatment (called "refractory").FL and MZL are subtypes of Non-Hodgkin 's lymphoma (NHL).This study will be made up of two parts (Part 1 not randomized, Part 2 randomized - controlled).The aim of…

Read more